Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ventilator Associated Pneumonia
- Sponsor
- Ain Shams University
- Enrollment
- 62
- Locations
- 1
- Primary Endpoint
- correlation between lung ultrasound and procalcitonin.
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
Ventilator Associated pneumonia (VAP) is associated with longer ICU length of stay, prolonged mechanical ventilation, and increased use of antimicrobials, health-care cost and mortality . Acute respiratory infections (ARIs) comprise a large and heterogeneous group of infections, including bacterial infections, viral infections, and infections of other etiologies. Early initiation of adequate antibiotic therapy is the cornerstone in the treatment. However, overuse of antibiotics and prolonged duration of antibiotic therapy in patients with bacterial ARIs in the hospital and intensive care setting is associated with increased resistance for common bacteria, high costs, and adverse drug reactions.
Investigators
Mona Ammar
Assistant professor
Ain Shams University
Eligibility Criteria
Inclusion Criteria
- •18 years old or greater
- •Ventilator associated pneumonia (VAP) with positive sputum culture.
Exclusion Criteria
- •pregnancy,
- •use of immunosuppressive agents except for steroids,
- •neutropenia (white blood cell count ≤1000/mL)
- •patients whose primary diagnosis was community acquired pneumonia and other source of infection.
Outcomes
Primary Outcomes
correlation between lung ultrasound and procalcitonin.
Time Frame: 7 days